Logo image of MOR

MorphoSys AG (MOR) Stock Analyst Ratings

USA - NASDAQ:MOR - US6177602025 - ADR

18.96 USD
+0.45 (+2.43%)
Last: 8/2/2024, 8:20:34 PM
18.96 USD
0 (0%)
After Hours: 8/2/2024, 8:20:34 PM
Buy % Consensus

70

ChartMill assigns a Buy % Consensus number of 70% to MOR. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 6.7. This target is -64.67% below the current price.
MOR was analyzed by 12 analysts. The buy percentage consensus is at 70. So analysts seem to be have mildly positive about MOR.
In the previous month the buy percentage consensus was at a similar level.
MOR was analyzed by 12 analysts, which is quite many. So the average rating should be quite meaningful.

Related screens

MOR Historical Analyst RatingsMOR Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -92 -83 -74 -65 -56 -47 -38 -29 -20 -11 -2 5 10 15 20

Price Target & Forecast

Price Low Median Mean High 18.962.673.506.7018.01 - -85.94% -81.54% -64.67% -4.99%

Related screens

MOR Current Analyst RatingMOR Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6
Up and Down Grades
Date Firm Action Rating
2024-03-14 Wells Fargo Downgrade Overweight -> Equal-Weight
2024-02-05 Wells Fargo Reiterate Overweight -> Overweight
2024-01-19 Morgan Stanley Downgrade Overweight -> Equal-Weight
2024-01-16 Morgan Stanley Downgrade Overweight -> Equal-Weight
2023-12-15 Wells Fargo Maintains Overweight -> Overweight
2023-12-05 JP Morgan Maintains Overweight -> Overweight
2023-11-22 Goldman Sachs Maintains Neutral -> Neutral
2023-11-21 JMP Securities Reiterate Market Outperform -> Market Outperform
2023-10-13 Morgan Stanley Upgrade Underweight -> Overweight
2023-09-15 Goldman Sachs Upgrade Sell -> Neutral
2023-06-22 JMP Securities Reiterate Market Outperform -> Market Outperform
2023-06-16 Wells Fargo Initiate Overweight
2023-06-16 JP Morgan Upgrade Underweight -> Overweight
2023-01-03 JP Morgan Downgrade Neutral -> Underweight
2022-11-18 JMP Securities Maintains Market Outperform
2022-01-14 Morgan Stanley Downgrade Overweight -> Equal-Weight
2021-08-06 Deutsche Bank Initiate
2021-08-04 JPMorgan Chase Initiate
2021-07-29 Berenberg Bank Initiate
2021-07-19 Barclays Initiate
2021-07-10 Morgan Stanley Initiate
2021-07-09 Morgan Stanley Initiate
2021-07-05 Stifel Nicolaus Initiate
2021-06-16 Berenberg Bank Initiate Buy
2021-06-14 JPMorgan Chase Initiate Neutral
2021-06-03 Deutsche Bank Initiate Buy
2021-06-03 Barclays Initiate Neutral
2021-06-02 JPMorgan Chase Initiate Buy
2021-05-24 Morgan Stanley Initiate Buy
2021-05-21 JPMorgan Chase Initiate Buy

MorphoSys AG / MOR FAQ

What is the price target for MOR stock?

12 analysts have analysed MOR and the average price target is 5.06 USD. This implies a price decrease of -73.33% is expected in the next year compared to the current price of 18.96.


Can you provide the consensus rating for MorphoSys AG stock?

The consensus rating for MorphoSys AG (MOR) is 70 / 100 . This indicates that analysts generally have a neutral outlook on the stock.